Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-03

FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for olanzapine from Aurobindo Pharma Limited under ANDA 203708, finalizing approval of a generic olanzapine product.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)